Filing Analysis
MGP Ingredients entered into Amendment No. 2 to its Credit Agreement and an Eighth Amendment to its Note Purchase Agreement on August 6, 2026. These amendments allow for EBITDA add-backs related to specific accounts receivable losses through December 31, 2027.
🚩 Red Flags
- The need for EBITDA add-backs specifically for accounts receivable losses suggests potential credit quality issues with certain customers.
- Company is currently operating under an 'Elevated Ratio Period' due to acquisition-related debt/obligations, indicating higher leverage than standard covenants allow.
📋 Key Facts
- Amendment No. 2 allows add-back of up to $20,000,000 in aggregate losses from specific customer accounts receivable for the period ending Dec 31, 2027.
- The company is currently utilizing an 'Elevated Ratio Period' (allowing net leverage up to 4.50:1) due to earnout obligations from the Penelope Bourbon LLC acquisition.
- Amendments were described by management as 'precautionary measures'.
- Management expects peak leverage to occur in Q3 2026, with a subsequent decline expected.
MGP Ingredients, Inc. filed an 8-K to furnish its second quarter 2026 financial results press release for the period ended June 30, 2026.
📋 Key Facts
- Company issued a press release regarding Q2 2026 financial results on July 29, 2026.
- The reporting period ended on June 30, 2026.
- The filing includes Exhibit 99.1 containing the press release.
MGP Ingredients announced the retirement of Board director Karen Seaberg and the subsequent appointment of CEO Julie Francis to fill her vacancy. Additionally, the company amended its bylaws regarding the process for filling board vacancies.
🚩 Red Flags
- None identified; the departure is a planned retirement and the replacement is the current CEO.
📋 Key Facts
- Director Karen Seaberg will retire from the Board effective December 14, 2025.
- CEO Julie Francis was elected by preferred stock holders to fill the Group B director vacancy, effective December 15, 2025.
- Julie Francis will not receive additional compensation for her board service.
- The Company amended and restated its Bylaws on December 11, 2025.
- Bylaw changes clarify that Group A director vacancies can be filled by common stockholders or the Board, while Group B vacancies are reserved for preferred stock holders.
MGP Ingredients, Inc. filed an 8-K to furnish its third quarter 2025 financial results press release for the period ended September 30, 2025.
📋 Key Facts
- Report date: October 29, 2025
- Reporting Period: Third Quarter 2025 (ended September 30, 2025)
- The filing includes a press release as Exhibit 99.1 regarding financial results.
MGP Ingredients, Inc. filed an 8-K to furnish its second quarter 2025 financial results press release for the period ended June 30, 2025.
📋 Key Facts
- Report date: July 31, 2025
- Reporting period: Second Quarter 2025 (ended June 30, 2025)
- The filing includes a press release as Exhibit 99.1 regarding financial results.
MGP Ingredients, Inc. has appointed Julie Francis as President and Chief Executive Officer, effective July 21, 2025. Brandon M. Gall will continue in his role as Chief Financial Officer following his interim tenure as CEO.
🚩 Red Flags
- Severance/Cause provisions include a requirement for the CEO to resign from any 'cannabis-related business activities' by the 2026 annual meeting, or it constitutes 'cause' for termination.
- Potential regulatory/compliance risk linked to the company's involvement in cannabis-related sectors.
📋 Key Facts
- Julie Francis appointed as President and CEO, effective July 21, 2025.
- Base salary set at $900,000 per annum.
- Target Short-Term Incentive (STI) is 100% of base salary.
- Target Long-Term Incentive (LTI) for 2025 is $2,300,000 (25% RSUs, 75% PSUs).
- Sign-on package includes a $100,000 cash bonus and stock options valued at $1,500,000.
- Relocation stipend of $100,000 provided in four installments.
- Employment agreement contains specific clauses regarding resignation from cannabis-related business activities.
MGP Ingredients, Inc. reported the results of its 2025 Annual Meeting of Stockholders held on May 20, 2025. The meeting included the election of directors and the ratification of KPMG LLP as independent auditors.
🚩 Red Flags
- None identified in the primary meeting results; however, the mention of 'Board of Director leadership changes' under Item 7.01 warrants monitoring for potential management instability.
📋 Key Facts
- Annual Meeting held on May 20, 2025.
- Group A directors (Gerke, Lux, Rauckman, Siwak) were elected by common stock holders.
- Group B directors were elected by preferred stock holders.
- KPMG LLP was ratified as the independent registered public accounting firm for 2025.
- Stockholders approved executive compensation on an advisory basis (Say-on-Pay).
- The company issued a press release regarding Board of Director leadership changes via Item 7.01.
MGP Ingredients, Inc. filed an 8-K to furnish its first quarter 2025 financial results (ended March 31, 2025) via a press release.
🚩 Red Flags
- Interim leadership: The CEO/CFO is listed as 'Interim', which can sometimes indicate recent management turnover or instability, though common in mid-cap transitions.
📋 Key Facts
- Reporting period: First Quarter 2025 ended March 31, 2025.
- Filing date: May 1, 2025.
- The filing includes Exhibit 99.1 containing the earnings press release.
- Signed by Brandon M. Gall, Interim President and CEO; VP, Finance and CFO.
MGP Ingredients, Inc. has entered into an Amended and Restated Credit Agreement and a Sixth Amendment to its Note Purchase Agreement. These actions primarily serve to extend debt maturities and increase available liquidity through higher credit facility limits.
🚩 Red Flags
- None identified; the filing describes debt restructuring/extension rather than distress.
📋 Key Facts
- Amended and Restated Credit Agreement with Wells Fargo Bank increases revolving credit facility from $400 million to $500 million.
- Maturity date of the revolving credit facility extended from May 14, 2026, to April 24, 2030.
- The agreement permits adding incremental term loan facilities or increasing revolving commitments by an additional $100 million (up to $200 million total increase).
- Sixth Amendment to Note Purchase Agreement extends the period for issuing up to $250 million in senior secured promissory notes from August 31, 2026, to April 24, 2028.
- The amendments include revisions to representations, covenants, and events of default.
MGP Ingredients, Inc. announced the election of two new independent directors, Gerardo I. Lopez and Martin Roper, to Group B members of the Board. Concurrently, Preet H. Michelson resigned from the Board effective April 14, 2025, stating her departure was not due to any disagreement with the company.
🚩 Red Flags
- None identified; departure is characterized as non-dispute related.
📋 Key Facts
- Gerardo I. Lopez and Martin Roper elected as Group B members of the Board on April 14, 2025.
- New directors appointed to Audit, Human Resources and Compensation, and Nominating and Governance Committees.
- Each new director received an equity grant of RSUs valued at $90,000, vesting on the second anniversary (April 16, 2027).
- Preet H. Michelson resigned from the Board effective April 14, 2025.
- Ms. Michelson's resignation was not due to any disagreement regarding company operations or policies.
MGP Ingredients, Inc. announced a redesign of its annual long-term incentive (LTI) program effective in 2025. The new structure shifts toward performance stock units (PSUs) with forward-looking financial goals and time-vested restricted stock units (RSUs).
📋 Key Facts
- The Human Resources and Compensation Committee approved a new LTI program design on March 11, 2025.
- New awards will consist of Performance Stock Units (PSUs) based on financial performance goals and time-vested Restricted Stock Units (RSUs).
- PSU vesting includes acceleration provisions for death, disability, or termination without cause/good reason within 18 months of a change in control.
- The RSU Award Agreement was updated specifically regarding retirement vesting provisions.
MGP Ingredients, Inc. announced that three members of its Board of Directors—Donn Lux, Karen Seaberg, and Lori Mingus—plan to sell shares of company common stock. The sales by Ms. Seaberg and Ms. Mingus are part of pre-established Rule 10b5-1 trading plans.
🚩 Red Flags
- Insider selling by multiple board members simultaneously can sometimes signal lack of confidence, though mitigated here by 10b5-1 plan disclosures.
📋 Key Facts
- Board members Donn Lux, Karen Seaberg, and Lori Mingus intend to sell Company common stock.
- Sales by Karen Seaberg and Lori Mingus involve transactions under Rule 10b5-1 plans adopted on March 12, 2024, and amended December 3, 2024.
- The company states the directors remain committed to the strategic vision and maintain significant equity stakes.
MGP Ingredients, Inc. filed an 8-K to announce the release of its financial results for the fourth quarter and full year ended December 31, 2024.
📋 Key Facts
- The filing relates to Q4 and Full Year 2024 financial results.
- Results were released via press release on February 26, 2025.
- Interim President and CEO/CFO Brandon M. Gall signed the report.
MGP Ingredients, Inc. announced that its Human Resources and Compensation Committee approved an amended and restated Short Term Incentive Plan (STIP), effective January 1, 2025. The plan is designed to reward employees based on the achievement of specific performance goals.
📋 Key Facts
- The STIP became effective on January 1, 2025.
- Plan eligibility includes executive officers and certain non-union employees.
- The Company will establish a cash bonus pool of at least 80% of the collective bonuses required based on actual performance.
- Clawback policies apply to awards granted under this plan.
- Provisions are included for participants terminated due to death, disability, or change in control.
MGP Ingredients announced a leadership transition where CEO David S. Bratcher will depart on December 31, 2024, to retire. CFO Brandon M. Gall has been appointed as Interim President and CEO effective January 1, 2025.
🚩 Red Flags
- Sudden leadership transition (CEO departure) can create short-term strategic uncertainty.
- Interim CEO appointment suggests a lack of an immediate permanent successor.
📋 Key Facts
- CEO David S. Bratcher's service ends Dec 31, 2024; he is also resigning from the Board of Directors.
- Brandon M. Gall (current CFO) appointed Interim President and CEO effective Jan 1, 2025.
- Interim CEO compensation includes a base salary increase to $525,000 and a one-time $100,000 supplemental cash incentive.
- A special RSU award of $525,000 was granted to the Interim CEO, vesting in two years.
- Donn Lux will succeed Karen Seaberg as Chairman of the Board effective Jan 1, 2025.
MGP Ingredients, Inc. filed an 8-K to announce the release of its financial results for the third quarter ended September 30, 2024.
📋 Key Facts
- Company issued a press release on October 31, 2024, regarding Q3 2024 financial results.
- The reporting period covered ends on September 30, 2024.
- The filing includes Exhibit 99.1 containing the full press release.
MGP Ingredients, Inc. issued an 8-K to announce the release of preliminary financial results for its third quarter ended September 30, 2024.
📋 Key Facts
- The company released preliminary financial results for Q3 2024 on October 17, 2024.
- The filing includes a press release (Exhibit 99.1) detailing the preliminary figures.
- The reporting period ended September 30, 2024.
This is an amendment (8-K/A) to a previously filed 8-K intended solely to correct the item number and title. The filing updates the classification from officer departures (Item 5.02) to amendments of bylaws (Item 5.03).
📋 Key Facts
- The filing is an Amendment No.1 to a Form 8-K filed on September 30, 2024.
- The purpose is to correct the item number from 'Item 5.02' to 'Item 5.03'.
- On September 26, 2024, the Board approved further amendment and restatement of the Company’s Bylaws.
- Bylaw changes include addressing Rule 14a-19 (Universal Proxy Rules) compliance, allowing preferred stock holders to act by majority written consent, and updating provisions regarding proxy confidentiality and board vacancy filling.
MGP Ingredients, Inc. announced that its Board of Directors approved amendments and restatements to the Company's Bylaws, effective September 26, 2024. The changes primarily focus on administrative updates, compliance with Universal Proxy Rules, and alignment with Kansas corporate statutes.
📋 Key Facts
- Board approved Amended and Restated Bylaws on September 26, 2024.
- Bylaws now address Rule 14a-19 (Universal Proxy Rules) requirements for stockholders.
- Preferred stock holders are now permitted to act by majority written consent rather than unanimous consent.
- The Board is granted customary authority to fill vacancies on the Board until the next annual meeting.
- Provisions regarding the confidentiality of stockholder votes from the Board/officers were removed.
- Bylaws updated to conform with current Kansas Statutes, including electronic communication allowances.
MGP Ingredients, Inc. filed an 8-K to furnish its second quarter 2024 financial results press release for the period ended June 30, 2024.
📋 Key Facts
- The filing is a standard earnings announcement under Item 2.02.
- Reporting period: Second Quarter 2024 (ended June 30, 2024).
- Filing date: August 1, 2024.
MGP Ingredients, Inc. held its 2024 Annual Meeting of Stockholders on May 23, 2024. The filing reports the results of shareholder votes regarding director elections, auditor ratification, executive compensation, and an equity incentive plan.
📋 Key Facts
- The 2024 Annual Meeting was held on May 23, 2024.
- Nine directors were elected to serve in Group A (Common Stock) and Group B (Preferred Stock).
- Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for 2024.
- Shareholders approved executive compensation on an advisory basis.
- The 2024 Equity Incentive Plan was approved by stockholders.
MGP Ingredients, Inc. filed an 8-K to announce its financial results for the first quarter of 2024, which ended on March 31, 2024.
📋 Key Facts
- The filing relates to Q1 2024 financial results (period ended March 31, 2024).
- The company issued a press release as Exhibit 99.1 containing the results.
- Reported by Brandon M. Gall, Vice President, Finance and Chief Financial Officer.
MGP Ingredients, Inc. announced the resignation of Curtis C. Landherr from his roles as Chief Legal Officer, Vice President, and Corporate Secretary, effective May 31, 2024. The company has entered into a transition agreement to ensure continuity while searching for a successor.
🚩 Red Flags
- Departure of a key named executive officer (CLO/Corporate Secretary).
📋 Key Facts
- Curtis C. Landherr is resigning as CLO, VP, and Corporate Secretary, effective May 31, 2024.
- He will cease officer roles on April 30, 2024, but remain a non-officer employee through May 31, 2024.
- Transition Agreement includes one year of base salary continuation and pro-rated 2024 short-term incentive award.
- The agreement includes reimbursement for relocation expenses up to $103,500 and monthly payments of $6,925 in May and June 2024.
- A one-time payment of $70,000 is due upon the final salary continuation payment, contingent on a release agreement.
MGP Ingredients, Inc. filed an 8-K to announce the release of its financial results for the fourth quarter and full year ended December 31, 2023.
📋 Key Facts
- Report date: February 22, 2024
- Reporting period: Fourth quarter and full year 2023 (ended Dec 31, 2023)
- The filing includes a press release as Exhibit 99.1 containing the financial results.
MGP Ingredients, Inc. announced the retirement of Stephen J. Glaser, Vice President of Production and Engineering, effective July 31, 2024.
📋 Key Facts
- Stephen J. Glaser is retiring from his role as Vice President of Production and Engineering.
- The departure is effective July 31, 2024.
- Glaser is a named executive officer of the Company.